Gongwin Biopharm Holdings Co Ltd

NEW
ROCO:6617 (Taiwan)  
NT$ 96.1 -2.4 (-2.44%) Aug 18
At Loss
P/B:
4.85
Market Cap:
NT$ 11.64B ($ 364.99M)
Enterprise V:
NT$ 10.06B ($ 315.58M)
Volume:
476.17K
Avg Vol (2M):
560.28K
Trade In:
Volume:
476.17K
At Loss
Avg Vol (2M):
560.28K

Gongwin Biopharm Holdings Co Ltd (ROCO:6617) Dividend

Gongwin Biopharm Holdings Co Ltd (ROCO:6617) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.7%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:6617 Dividend

Does Gongwin Biopharm Holdings Co Ltd (ROCO:6617) pay a dividend?

Gongwin Biopharm Holdings Co Ltd (ROCO:6617) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Gongwin Biopharm Holdings Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Gongwin Biopharm Holdings Co Ltd has returned capital to shareholders via buybacks at a rate of -2.7% over the past 3 years.

What are dividend-paying alternatives to Gongwin Biopharm Holdings Co Ltd?

For dividend-paying alternatives in Gongwin Biopharm Holdings Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.